← Leaderboards
Julie Ann Sosa
Duke University
$2,062,170
Attributed
$4,124,339
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $781.8K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,463,713 · 2
FDA$1,660,626 · 1
By mechanism
R01$3,710,424 · 2
R21$413,915 · 1
Top collaborators
- Elizabeth Gardner Grubbs4 shared
- Heather Yeo3 shared
- James Koh2 shared
Most similar at Duke University
Same institution · by research overlap
- James Koh$2,469,983
- Steven R Patierno$12,611,775
- Joseph Patrick McEvoy$4,681,380
- Paul P Lee$8,007,038
- Nelson J. Chao$27,968,804
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanOperative Surgical ProceduresFollow-UpCharacteristicsClinical TrialsComplexCovid-19 PandemicAdministratorCertificationAsianClient SatisfactionAccreditationCohortCollaborationsAmericanCare OutcomesAcademic Medical CentersCareerAreaBlack MenBlack PopulationsBlack RaceAssociation Of American Medical CollegesAlly
Grant awards (9)
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce$598,657
R01 · FY2025 · MD
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce$669,355
R01 · FY2024 · MD
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce$781,786
R01 · FY2023 · MD
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management$394,692
R01 · FY2022 · FD
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management$398,554
R01 · FY2021 · FD
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management$363,819
R01 · FY2020 · FD
A novel natural history study of medullary thyroid carcinoma: Incorporating the patient perspective to inform advanced disease management$503,561
R01 · FY2019 · FD
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia$218,735
R21 · FY2016 · CA
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia$195,180
R21 · FY2015 · CA